DrugPatentWatch Database Preview
Profile for Germany Patent: 60239146
US Patent Family Members and Approved Drugs for Germany Patent: 60239146
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Mar 25, 2023 | Pfizer Inc | XELJANZ XR | tofacitinib citrate |
➤ Sign Up | Mar 25, 2023 | Pf Prism Cv | XELJANZ | tofacitinib citrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |